Events
Seminars
Neurotherapeutics Seminar Series
June 29, 2026, 12:00 - 1 p.m. CT
Texas A&M Health Bryan Campus—MREB II Room 1403
The Texas A&M Health Institute of Pharmacology and Neurotherapeutics (IPN) is hosting a seminar by Dr. Amy Brooks-Kayal. Join us to learn about JAK-STAT inhibition as a disease-modifying approach for epilepsy and brain diseases.
JAK-STAT Inhibition as a Disease-Modifying Approach for Epilepsy
Amy Brooks-Kayal, MD, FAAN, FANA, FAES
Professor and Chair, Department of Neurology, Andrew John Gabor, M.D., Ph.D. Presidential Endowed Chair, University of California, Davis, School of Medicine, Sacramento, CA
This is offered both in person (lunch included) and via Zoom.
Zoom link:
https://tamu.zoom.us/j/92450361046?pwd=xS7N63OUgSOdRwqwt9naBHI7lwa39s.1
Meeting ID: 924 5036 1046
Passcode: 008585
About the speaker:
Amy R. Brooks-Kayal, MD, is professor and chair of the Department of Neurology at the University of California Davis School of Medicine, where she leads major clinical, research and educational initiatives in neurological disorders. She is an internationally recognized physician-scientist and one of the foremost leaders in epilepsy research and clinical pediatric neurology. Dr. Brooks-Kayal received her Bachor of Science in biology and psychology from Cornell University (1980) and her medical degree from Johns Hopkins University (1984), followed by pediatric residency, child neurology residency and neuroscience fellowship training at the University of Pennsylvania and the Children’s Hospital of Philadelphia.
Her research has focused on molecular and cellular mechanisms of epileptogenesis, particularly GABA-A receptor signaling and network remodeling following brain injury. Her pioneering discoveries established the critical roles of GABA receptor subunit plasticity and JAK/STAT signaling in the development of epilepsy and laid the foundation for novel strategies to prevent epilepsy and its comorbidities.
Over a distinguished 30-year career, she has authored hundreds of papers and maintained continuous NIH funding. She is a past president of the American Epilepsy Society (AES), served on the NINDS Advisory Council, and has held numerous leadership roles within the American Academy of Neurology, ILAE, Child Neurology Society and the Society for Neuroscience. She received many honors, including the ILAE Ambassador for Epilepsy Award, the AES Founders Award, the Bernard Sachs Award and the Women & Philanthropy Impact Award from UC Davis. In addition, she is widely recognized for her mentorship of trainees and leadership in shaping national epilepsy research priorities and improving the lives of individuals affected by epilepsy worldwide.
May 18, 2026
Modifiable Features of Brain and Systemic Aging with Senotherapeutics
Chase Carver, PhD, Assistant Professor of Physiology, Schafer Brain and Systemic Aging Laboratory, Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN
View May 18 Seminar Flyer PDF
July 21, 2025
Neuroinflammation as a Therapeutic Target for Mitigating the Long-Term Impact of Organophosphate Intoxication
Dr. Pamela J. Lein, Ph.D., Distinguished Professor of Neurotoxicology, Chair, Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, Davis, CA.
View July 21 Seminar Flyer PDF
June 30, 2025
Targeting TRP channels to counteract chemical threat agents-induced pulmonary and cutaneous injuries
Dr. Satya Achanta, D.V.M., Ph.D, Assistant Professor, Department of Anesthesiology, Duke University School of Medicine, Durham, NC.
View June 30 Seminar Flyer PDF
April 28, 2025
Developing Metabolism-based Therapies for Epilepsy and its Co-morbidities
Dr. Manisha Patel, Ph.D, Professor and Associate Dean for Research and Graduate Studies, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO.
View April 28 Seminar Flyer PDF
March 31, 2025
Glial and Immune Contributions to Infection-Indueced Seizures in a Mouse Model of Temporal Lobe Epilepsy
Dr. Karen S. Wilcox, Distinguished Professor and Chair, Richard L. Stimson Presidential Endowed Chair, College of Pharmacy, University of Utah, Salt Lake City, UT.
View March 31 Seminar Flyer PDF
November 25, 2024
Translational Therapy Development Programs at the National Institute of Neurological Disorders and Stroke (NINDS)
Dr. Brian Klein, Program Director, Epilepsy Therapy Screening Program, Division of Translational Research, National Institute of Neurological Disorders and Stroke, Rockville, MD.
View Nov. 25 Seminar Flyer PDF
October 28, 2024
Novel Mechanism Based Biomarker and Therapeutic Strategies for Parkinson’s Disease
Dr. Anumantha Kanthasamy, Inaugural Johnny Isakson Chair in Parkinson’s Research, Professor of Physiology and Pharmacology,
Director, Isacson Center for Neurological Disease Research at the College of Veterinary Medicine, University of Georgia.
View Oct. 28 Seminar Flyer PDF
October 4, 2024
Role of Clinical Pharmacology in Drug Development
Dr. Krishna R. Devarakonda , Founder & Chief Scientific Officer, 6-S Pharma Inc., Ex-Vice President of Clinical Development, Mallinckrodt Pharmaceuticals
View Oct. 4 Seminar Flyer PDF
July 29, 2024
Gut-Microbiota-Brain Axis and Post-traumatic Epilepsy
Andrey Mazarati, MD, PhD, Professor, Dept. of Pediatrics/Neurology Division,
David Geffen School of Medicine at UCLA, Los Angeles, CA
View July 29 Seminar Flyer PDF
Workshops
National Workshop on Experimental PTE Models (March 10, 2023)
Scientific Training Workshop (July 2022)
High-Impact Scientific Writing Workshop for Students and Postdoc Scholars
This workshop consists of three separate sessions in a hybrid (in-person and online) format.
Session 1: Scientific Publication Tips: An Introduction to High Impact Science Writing (June 2022). This 80-min session was held as part of the IPN June seminar.
Session 2: Online High Impact Science Writing eCourse (July 2022)– Nine self-paced online video modules (~ 7 hr to complete), pre-and post-tests to measure your learning gains, quizzes to practice your skills, downloadable workbook, and receive a Certificate of Completion for this eCourse.
Session 3: The Art and Method of Writing a Scientific Manuscript. In person, interactive “Wrap-Up” session (July 25, 2022)– This session will cover eight topics that will prepare you to write your next scientific manuscript by applying high-impact science writing. This is followed by an interactive Q&A Session.
Research Symposium
2025 Annual Research Symposium
Texas A&M Institute of Pharmacology and Neurotherapeutics (IPN)
September 5th – 10:00 am – 1:45 pm CT
HSC Bryan Campus/ MREB-2 Room 1403
On behalf of Texas A&M Health Institute of Pharmacology and Neurotherapeutics (IPN), a multi-college institute for research training and building synergies among brain scientists for new drug discovery and development, we would like to invite you to the 3rd Annual Research Symposium.
Join us for this annual event featuring poster presentations from undergrads, graduates, and postdocs!
Lunch Provided
Submit an abstract (any research related to pharmacology, neuroscience, and neurotherapeutics) now at https://forms.gle/2gSny6WLqzT8oXrL9
Deadline for registration and abstract: September 1, 2025
Keynote Seminar
Individualized AI-Guided Neuromodulation of Brain Networks: Precision Medicine from Feasibility to Treatment
T. Dorina Papageorgiou, Ph.D.
Assistant Professor of Psychiatry, Neuroscience, Physical Medicine & Rehabilitation, Baylor College of Medicine, Houston, TX
Program Schedule (September 5, 2025)
10:00-12:00 pm Poster Presentations MREB-2 Lobby
12:00-12:30 pm Lunch MREB-2 1403
12:30-1:30 pm Keynote Seminar: Dorina Papageorgiou, Ph.D.
Assistant Professor, Baylor College of Medicine
01:30-1:45 pm Closing Remarks & Awards MREB-2 1403
Program Chair:
Dr. Samba Reddy, Founding Director, IPN
For more info, contact:
Dr. Sreevidhya Ramakrishnan (sreevidh@tamu.edu)
View Flyer
IPN 2nd Annual Research Symposium
August 29, 2024, 10:00 a.m. – 1:45 p.m CT.
Texas A&M Institute of Pharmacology and Neurotherapeutics (IPN)
HSC Bryan Campus/ MREB-2 Room 1403
On behalf of Texas A&M Health Institute of Pharmacology and Neurotherapeutics (IPN), a multi-college institute for research training and building synergies among brain scientists for new drug discovery and development, we would like to invite you to the 2nd Annual Research Symposium.
Join us for this annual event featuring poster presentations from undergrads, graduates, and postdocs!
Lunch Provided
Submit an abstract at:
https://forms.gle/2gSny6WLqzT8oXrL9
(Topics: research related to biomedical, pharmacology, neuroscience, neural computations, pharmaceuticals, and therapeutics)
Deadline for registration (free) and abstract: August 23, 2024
Keynote Seminar
Artificial Intelligence in Medicine:
Impact on Drug Development and the Delivery of Care
Keynote Speaker
Joe Cunningham, M.D.
Founder and Managing Director, Sante Ventures, Austin, TX 78701
Chairman, Texas A&M Council on Innovation
Program Schedule (August 29, 2024)
10:00-12:00 pm Poster Presentations MREB-2 Lobby
12:00-12:30 pm Lunch MREB-2 1403
12:30-1:30 pm Keynote Seminar, Joe Cunningham, M.D. Founder and Managing Director, Sante Ventures
01:30-1:45 pm Closing Remarks & Awards MREB-2 1403
Program Chair:
Dr. Samba Reddy, Founding Director, IPN
For more info, contact:
Dr. Sreevidhya Ramakrishnan
Training Programs
- Postdoctoral Training Program
- Undergraduate Research Program
Courses
- Neuroscience and Pharmacology Courses
- IP, Patent Applications & Commercialization
Research Projects
- IPN Collaboration Projects